Sales Growth YoY (Last Twelve Months): Lumos Therapeutics (LUMO)

Graphic logo of Lumos Pharma, Inc. (LUMO)

Lumos Pharma, Inc. (LUMO) is integrating ESG standards and bioethics into the development of drugs for rare pathologies. Year-over-year revenue dynamics over the last 12 months illustrate the financial trend, where 41.70 indicates the level of this metric. Intense competition for patents in the metabolic sector creates risks, while the R&D stage for growth hormone limits scaling due to a lack of current sales.

Sales Growth YoY (Last Twelve Months): Lumos Pharma Corp (LUMO) for 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for Lumos Pharma (LUMO)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:LUMO (Lumos Therapeutics)
Mass-produced product of lumos-pharma.com

As a portfolio manager, I utilize this indicator to verify cash flow resilience under stress conditions. The year-over-year product sales volume dynamics for the TTM measure the percentage change in revenue over a rolling year, which allows for the identification of revenue stagnation at Lumos Pharma, Inc. (LUMO) amid a critical deficit of commercial receipts and high R&D expenditure pressure.

Competitors of Lumos Pharma, Inc. (LUMO)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Agape ATP - Trailing Twelve Months Sales Growth|Revenue Growth YoY (Last 12 Months) PLUR (Pluri Inc)|Annual Revenue Growth (Last Twelve Months) Synlogic Inc.|Sales Growth YoY (Last Twelve Months) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Trailing Twelve Months Revenue Growth|Spruce Biosciences Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)